Semaglutide and human reproduction: caution at the intersection of energy balance, ovarian function, and follicular development
Abstract Obese or overweight patients considering IVF are generally counselled to reduce weight closer to target BMI (i.e., < 30 kg/m2) by interventions entailing dietary change with a structured exercise program. There is little disagreement that supervised weight loss can improve reproductive o...
Saved in:
| Main Authors: | E. Scott Sills, Conor Harrity, Howard I. Chu, Jing-Wen Wang, Fan Yang, Samuel H. Wood |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Reproductive Biology and Endocrinology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12958-025-01435-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial
by: Haiyan Chen, et al.
Published: (2025-07-01) -
Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment
by: Rui Salvador, et al.
Published: (2025-03-01) -
The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort
by: Eman A. Toraih, et al.
Published: (2025-04-01) -
Semaglutide‐Induced Hepatic Injury: A Rare Case of Drug Induced Liver Injury
by: Rupayan Kundu, et al.
Published: (2025-08-01) -
A GLP-1 analogue optimized for cAMP-biased signaling improves weight loss in obese mice
by: Jonathan D. Douros, et al.
Published: (2025-10-01)